Pharmacist’s Perspective on Artificial Intelligence and Barriers towards its Adoption in Community Pharmacy
No Thumbnail Available
Files
Date
2025
Journal Title
Journal ISSN
Volume Title
Publisher
Library Information Services, COMSATS University Islamabad, Lahore Campus
Abstract
Artificial intelligence (AI) is remarkably changing pharmacy practice by improving
patient-care, clinical decision-making, and medication management. Even though AI
has a lot of potential, it is still not widely adopted in community pharmacies, especially
in developing countries like Pakistan, because of knowledge gaps, lack of training, and
various technological, organizational, and ethical barriers. The aim of this study is to
explore the knowledge, attitude, and willingness of community pharmacists (CPs) in
Punjab, Pakistan, toward the adoption of AI, and it will also look for barriers that might
make it hard to integrate into pharmacy practice. A cross-sectional study was conducted
using a structured questionnaire in several cities of Punjab. Most CPs reported having
heard of the term AI (95.2%), but most of them have a moderate level of knowledge of
AI applications (35.2%). The CPs were very open; their attitude towards adopting AI
applications in community pharmacy was strong and positive, but with concerns about
the effect of AI on job security. The perceived barriers reported by the majority of CPs
were a lack of AI information, difficulty to apply AI, a lack of training, a lack of time,
and high running cost. In general, CPs demonstrated that most of them are willing to
implement AI and have a positive attitude towards the adoption of AI, but there are still
significant barriers limiting its adoption in community pharmacy practice. The findings
suggest that there is an urgent need to design training programs, update the curriculum,
and conduct seminars to address the challenges and potential of AI applications.
Description
Keywords
Department of Pharmacy, SP24, Pharmacy, Artificial Intelligence (AI), Community Pharmacy, Pharmacists’ Perspective, Dr. Imran Nazir